Clinical Trial Update: Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares mitoxantrone hydrochloride liposome injection to chidamide in patients with relapsed/refractory peripheral T-cell lymphoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Peripheral T Cell Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING